Publications Database

Campbell M. et al. (1990)

Naltrexone in autistic children: a double-blind and placebo-controlled study.

Psychopharmacology Bulletin

26(1), pp. 130-135

Read Abstract (New Window)

Campbell M. et al. (1989)

Naltrexone in autistic children: an acute open dose range tolerance trial.

Journal of the American Academy of Child and Adolescent Psychiatry

28(2), pp. 200-206

Read Abstract (New Window)

Campbell M. et al. (1993)

Naltrexone in autistic children: behavioral symptoms and attentional learning.

Journal of the American Academy of Child and Adolescent Psychiatry

32(6), pp. 1283-1291

Read Abstract (New Window)

Campbell M. (1998)

Naltrexone in infantile autism.

Psychopharmacology Bulletin

24(1), pp. 135-139

Campbell M. (1975)

Pharmacotherapy in early infantile autism.

Biological Psychiatry

10(4), pp. 399-423

Read Abstract (New Window)

Campbell M. , Cueva J. E. (1995)

Psychopharmacology in child and adolescent psychiatry: a review of the past seven years: Part 1

Journal of the American Academy of Child and Adolescent Psychiatry

34(9), pp. 1124-1132

Read Abstract (New Window)

Campbell M. et al. (1972)

Response to triiodothyronine and dextroamphetamine: A study of preschool schizophrenic children.

Journal of Autism and Developmental Disorders

2(4),

Read Abstract (New Window)

Campbell M. et al. (1986)

Short-term efficacy and safety of fenfluramine in hospitalized preschool-age autistic children: an open study.

Psychopharmacology Bulletin

22(1), pp. 141-147

Campbell M. et al. (1990)

Stereotypies and tardive dyskinesia: abnormal movements in autistic children.

Psychopharmacology Bulletin

26(2), pp. 260-266

Read Abstract (New Window)

Campbell M. et al. (1982)

The effects of haloperidol on learning and behavior in autistic children.

Journal of Autism and Developmental Disorders

12(2), pp. 167-175

Read Abstract (New Window)

Campbell A. , Tincani M. J. (2011)

The power card strategy: Strength-based intervention to increase direction following of children with autism spectrum disorder.

Journal of Positive Behavior Interventions

13(4), pp. 240-249

Read Abstract (New Window)

Campolo D. et al. (2008)

A novel technological approach towards the early diagnosis of neurodevelopmental disorders.

Conf Proc IEEE Eng Med Biol Soc

1 pp. 4875-4878

Read Abstract (New Window)

Canitano R. (2005)

Clinical experience with topiramate to counteract neuroleptic induced weight gain in 10 individuals with autistic spectrum disorders.

Brain and Development

27(3), pp, 228-232

Read Abstract (New Window)

Canitano R. (2015)

Mood stabilizers in children and adolescents with autism spectrum disorders.

Clinical Neuropharmacology

September, 38(5), pp. 177-182.

Read Abstract (New Window)

Canitano R. (2013)

Novel treatments in autism spectrum disorders: from synaptic dysfunction to experimental therapeutics.

Behavioural Brain Research

251 pp. 125-132.

Read Abstract (New Window)

Canitano R. , Scandurra V. (2011)

Psychopharmacology in autism: An update.

Progress in Neuro-Psychopharmacology and Biological Psychiatry

35(1), pp. 18-28.

Read Abstract (New Window)

Canitano R. , Scandurra V. (2008)

Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents.

Neuropsychiatric Disease and Treatment

4(4), pp. 723-730

Read Abstract (New Window) Read Full (New Window)

Canitano R. (2006)

Self injurious behavior in autism: clinical aspects and treatment with risperidone.

Journal of Neural Transmission

113(3), pp. 425-431

Read Abstract (New Window)

Cannell J. J. (2008)

Autism and vitamin D.

Medical Hypotheses

70(4), pp. 750-759

Read Abstract (New Window)

Cannell J. J. , Hollis B. W. (2008)

Use of vitamin D in clinical practice.

Alternative Medicine Review

13(1), pp. 6-20

Read Abstract (New Window) Read Full (New Window)